Bayer to Stop Selling Controversial Sterilization Device Following Mounting Lawsuits and Complaints
PRI Celebrates Victory for Women’s Health
by Jonathan Abbamonte
Population Research Institute
After years of litigation and sustained pressure from thousands of women who have reported injuries and other adverse side effects from the Essure sterilization coil, Bayer, the device’s manufacturer, has announced that it will discontinue selling Essure in the United States by the end of the year.
In a press release last Friday, Bayer announced that it would cease selling or distributing Essure after December 31st. Bayer also notified the U.S. Food and Drug Administration (FDA) on Friday of its decision to withdraw the device.
Since Essure was first approved by the FDA in 2002, the FDA has received nearly 27,000 adverse events reports associated with the device including reports of persistent abdominal pain, severe allergic and autoimmune reactions, bleeding, bloating, hair loss, headaches, device migration, device breakage, and perforation of the uterus, fallopian tubes or other organs. Bayer has also independently received over 30,000 complaints for the device.
Read more here
The Population Research Institute is a (501c3) non-profit research organization whose core values hold that people are the world’s greatest resource. PRI’s goals are to educate on this premise, to expose the myth of overpopulation, and to expose human rights abuses committed in population control programs. Our growing, global network of pro-life groups spans over 30 countries. For more information, please use this link.
Pregnant, need help or know someone who does?
National Hotline: Call 1-800-712-HELP or Text 'HELPLINE' to 313131.
In Southeast Penna: Call the Community Women's Center at 215-826-8090
If you or someone you know is suffering after abortion, confidential non-judgmental help is available. Call Project Rachel's national toll-free number 888-456-HOPE (4673) or visit hopeafterabortion.org.
No comments:
Post a Comment